Clinical Trials Browser

Phase 2 × Sarcoma × balstilimab × Clear all

NCT04028063 2026-04-20

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

Phase 2 Active not recruiting

Sarcoma